Protocol library

SingleNot ApprovedEarly HumanSourced

AOD-9604

A modified growth-hormone fragment investigated for obesity. Human development did not establish an authorised obesity treatment or a routine-use protocol.

Evidence context, not a personal protocol

Quantities below reproduce study or label context. They do not assess suitability, product equivalence or individual risk.

Regimens studied

Adults with obesity enrolled in clinical development studies

Oral and intravenous research formulations were evaluated across early studies

The studies did not establish a subcutaneous research-vial regimen for routine use.

Evidence summary

The human development programme does not support the confident dosing schedules commonly repeated by commercial protocol sites.

Protocol status

This page documents the evidence gap rather than presenting an unsupported injectable schedule.

Warnings and contraindications

AOD-9604 is not an authorised medicine for weight management.

Commercial protocol claims exceed the conclusions supported by controlled human evidence.